CENTER OF

 

 

 

 

REGENERATIVE MEDICINE

 

 

 

 

ADVANCING REGENERATIVE MEDICINE THROUGH EXCELLENCE
IN EDUCATION AND COLLABORATIVE RESEARCH

 

 

 

 

  1. CRM Co-Directo Farsh Guilak was recently interviewed on The Stem Cell Podcast about their recent paper reporting the creation of SMART stem cells for arthritis treatment.

  2. Click below to listen.

   

 

 

"The SARM1 Toll/Interleukin-1 receptor domain possesses intrinsic NAD+ cleavage activity that promotes pathological axon degeneration.  Essman K, DiAntonio A, & Milbrandt J, et al. Neuron 93:1334-1343, 2017. Paper

 

      1.  

        "Therapeutic efficacy of intra-articular hyaluronan derivative and platelet-rich plasma in mice following axial tibial loading. Duan X, Sandell LJ, Chinzei N, Holguin N, Silva MJ, Schiavinato A, Rai MF. PLoS ONE 12:e0175682, 2017.

       

       

Read more >>

 

 

 

hPSC Pilot Grants and Subsidies


Pilot grants and subsidies are available through the support of the CDI.

Pilot grant deadline: June 5, 2017

Full details can be found here.

 

 


 

 

Contact Us  |  Giving  |  wustl

 

Center of Regenerative Medicine, Campus Box 8103, 660 South Euclid Ave., St. Louis, MO 63110-1093